Skip to main content

Advertisement

Table 3 Medical cost estimation

From: Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

(Unit: USD)    
  GEM-E GEM p-valuea
  (n = 1,331) (n = 2,936)  
Inpatient cost (Mean ± SD)b 14,846.70 ± 11,865.27 13,211.07 ± 1,0931.57 <0.0001
Length of stay (Mean ± SD) 64 ± 53 63 ± 54 0.8032
Outpatient cost (Mean ± SD)b 6,152.29 ± 7,233.05 6,066.95 ± 7,001.03 0.6920
Medication cost (Mean ± SD)b 3,264.00 ± 4,579.44 1,169.20 ± 1,644.40 <0.0001
Total medical costs (Mean ± SD)b 23,819.51 ± 15,106.18 19,927.98 ± 14,444.86 <0.0001
  1. Abbreviation: GEM Gemcitabine, GEM-E Gemcitabine + Erlotinib
  2. aDifferences between GEM and GEM-E was tested with t-test after log transformation
  3. bAverage 2013 exchange rate: one US dollar (USD) = 1,113.85 Korea Won (KRW)